tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
HALO is currently covered by 8 analysts with an average price target of $71.62. This is a potential upside of $6.43 (9.86%) from yesterday's end of day stock price of $65.19.
Halozyme Therapeutics's activity chart (see below) currently has 231 price targets and 167 ratings on display. The stock rating distribution of HALO is 30% HOLD, 66.67% BUY and 3.33% SELL.
Analysts average stock forecasts to be materialized ratio is 91.3% with an average time for these price targets to be met of 291.84 days.
Highest price target for HALO is $90, Lowest price target is $53, average price target is $73.75.
Most recent stock forecast was given by JESSICA FYE from JPMORGAN on 27-Oct-2025. First documented stock forecast 11-Jun-2014.
Currently out of the existing stock ratings of HALO, 9 are a HOLD (30%), 20 are a BUY (66.67%), 1 are a SELL (3.33%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$65
$-0.19 (-0.29%)
$63
7 days ago
(27-Oct-2025)
11/11 (100%)
$-0.85 (-1.29%)
70
Buy
$79
$13.81 (21.18%)
$80
14 days ago
(20-Oct-2025)
8/10 (80%)
$12.53 (18.85%)
234
Sell
$70
$4.81 (7.38%)
$42
20 days ago
(14-Oct-2025)
3/4 (75%)
$3.35 (5.03%)
453
Buy
$90
$24.81 (38.06%)
$85
1 months 1 days ago
(02-Oct-2025)
31/33 (93.94%)
$18.31 (25.54%)
183
Buy
$90
$24.81 (38.06%)
$75
1 months 10 days ago
(24-Sep-2025)
6/7 (85.71%)
$14.36 (18.98%)
253
What is HALO (Halozyme Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on HALO (Halozyme Therapeutics) with a proven track record?
Which analyst has the most public recommendations on HALO (Halozyme Therapeutics)?
Which analyst is the currently most bullish on HALO (Halozyme Therapeutics)?
Which analyst is the currently most reserved on HALO (Halozyme Therapeutics)?
